Rapid diagnosis of bloodstream infections in the critically ill: Evaluation of the broad-range PCR/ESI-MS technology
Open Access
- 15 May 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (5) , e0197436
Abstract
Bloodstream infection (BSI) and associated sepsis represent a major source of mortality in industrialized countries. Prompt treatment with targeted antibiotics affects both the financial impact and the clinical outcome of BSI: every hour gained in initiating the correct antimicrobial therapy significantly increases the probability of patient survival. However, the current standard-of-care, which depends on blood culture-based diagnosis, are often unable to provide such a fast response. Fast and sensitive molecular techniques for the detection of sepsis-related pathogens from primary blood samples are strongly needed. The aim of this study was to assess the usefulness of the IRIDICA BAC BSI Assay, a PCR/ESI-MS-based technology for the early diagnosis of bloodstream infections from primary blood samples in critical patients. This evaluation has been performed by comparison with the traditional culture-based methods. The study was performed on a total of 300 prospective whole blood specimens obtained from patients suspected of sepsis, admitted to enrolling ER units from The Greater Romagna Area. The overall concordance between the two techniques was of 86%, with a calculated sensitivity of 76% and an assay specificity of 90%. The clinical significance of discrepant results was evaluated reviewing the patients’ clinical records and the results of additional relevant microbiological tests. The data here obtained support the ability of the IRIDICA BAC BSI Assay to identify a broad range of bacteria directly from primary whole blood samples, within eight hours. This might allow a timely administration of a suitable treatment.Keywords
Funding Information
- Abbott Molecular Italia (BSI-2015)
This publication has 33 references indexed in Scilit:
- The Potential for PCR Based Testing to Improve Diagnosis and Treatment of SepsisCurrent Infectious Disease Reports, 2013
- Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patientsDiagnostic Microbiology and Infectious Disease, 2013
- How Can the Microbiologist Help in Diagnosing Neonatal Sepsis?International Journal of Pediatrics, 2012
- Evaluation of a commercial multiplex PCR test (SeptiFast) in the etiological diagnosis of community-onset bloodstream infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Conventional and molecular techniques for the early diagnosis of bacteraemiaInternational Journal of Antimicrobial Agents, 2010
- Antibiotic Use in Thailand: Quantifying Impact on Blood Culture Yield and Estimates of Pneumococcal Bacteremia IncidenceThe American Journal of Tropical Medicine and Hygiene, 2010
- New technology for rapid molecular diagnosis of bloodstream infectionsExpert Review of Molecular Diagnostics, 2010
- Diagnosis of bloodstream infections in immunocompromised patients by real-time PCRJournal of Infection, 2009
- Laboratory diagnosis of late-onset sepsis in newborns by multiplex real-time PCRJournal of Medical Microbiology, 2009
- Broad‐Spectrum Antimicrobials and the Treatment of Serious Bacterial Infections: Getting It Right Up FrontClinical Infectious Diseases, 2008